Center for Clinical Genomics, Kanazawa Medical University Hospital, Ishikawa, Japan.
Division of Genomic Medicine, Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan.
RNA Biol. 2021 Nov;18(11):1600-1607. doi: 10.1080/15476286.2021.1872961. Epub 2021 Jan 20.
Alternative splicing is a regulated process by which eukaryotic genes may produce diverse biological products. Defects in the process typically affect cellular function and can lead to disease. Next-generation sequencing (NGS) technologies have been developed to detect alternative splicing events; however, the alternative splicing events detected by standard RNA-Seq may or may not be derived from full-length RNA. The SMARTer method provides full-length double-strand cDNA synthesis, and the resulting gene expression patterns correlate strongly with standard RNA-Seq. However, it also yields non-specific genomic DNA amplification. We improved the SMARTer method by employing a target-capture full-length double-strand cDNA sequencing method. High-fidelity, full-length cDNA is generated by the SMARTer method, followed by target-specific capture with exon probes. The expression pattern observed with this SMARTer Capture method was highly correlated with the results of the original SMARTer method. The number and accuracy of the detected splicing events were increased by eliminating non-specific genomic DNA amplification by the SMARTer Capture. Compared to the original SMARTer method, the SMARTer Capture provided 4-fold greater detection of alternative splicing events at the same read number, and it took less than 1/100 of read number to detect the same number of splicing events. The percent splicing in index (PSI) of the SMARTer Capture is highly correlated with the PSI of the SMARTer. These results indicate that the SMARTer Capture represents an improvement of the SMARTer method to accurately characterize alternative splicing repertories in targeted genes without biases.
可变剪接是一种受调控的过程,通过该过程真核基因可以产生多种生物产物。该过程的缺陷通常会影响细胞功能,并可能导致疾病。下一代测序(NGS)技术已被开发用于检测可变剪接事件;然而,标准 RNA-Seq 检测到的可变剪接事件可能并非源自全长 RNA。SMARTer 方法提供全长双链 cDNA 合成,并且得到的基因表达模式与标准 RNA-Seq 高度相关。然而,它也会产生非特异性基因组 DNA 扩增。我们通过采用靶向捕获全长双链 cDNA 测序方法改进了 SMARTer 方法。SMARTer 方法生成高保真度的全长 cDNA,然后用外显子探针进行靶向特异性捕获。与原始 SMARTer 方法相比,这种 SMARTer Capture 方法观察到的表达模式与 SMARTer 方法的结果高度相关。通过 SMARTer Capture 消除非特异性基因组 DNA 扩增,增加了检测到的剪接事件的数量和准确性。与原始 SMARTer 方法相比,SMARTer Capture 在相同的读取次数下,检测到的可变剪接事件增加了 4 倍,而检测相同数量的剪接事件所需的读取次数不到原始 SMARTer 方法的 1/100。SMARTer Capture 的索引剪接百分比(PSI)与 SMARTer 的 PSI 高度相关。这些结果表明,SMARTer Capture 是 SMARTer 方法的改进,可以在没有偏倚的情况下准确地描述靶向基因中的可变剪接库。